These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8578769)

  • 1. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of the enantiomers of mexiletine in humans.
    Igwemezie L; Kerr CR; McErlane KM
    Xenobiotica; 1989 Jun; 19(6):677-82. PubMed ID: 2763576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereoselective serum protein binding of mexiletine enantiomers in man.
    McErlane KM; Igwemezie L; Kerr CR
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):141-4. PubMed ID: 3589151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their stereoselective disposition in man.
    McErlane KM; Igwemezie L; Kerr CR
    J Chromatogr; 1987 Apr; 415(2):335-46. PubMed ID: 3584372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective metabolism of mexiletine in Chagasic women with ventricular arrhythmias.
    Lanchote VL; Cesarino EJ; Santos VJ; Moraes Júnior AV; Zanardi AM; Santos SR
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):259-66. PubMed ID: 9725491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective disposition of the antiarrhythmic agent mexiletine during the concomitant administration of caffeine.
    Labbé L; Abolfathi Z; Robitaille NM; St-Maurice F; Gilbert M; Turgeon J
    Ther Drug Monit; 1999 Apr; 21(2):191-9. PubMed ID: 10217339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of polymorphic debrisoquin 4-hydroxylase activity in the stereoselective disposition of mexiletine in humans.
    Abolfathi Z; Fiset C; Gilbert M; Moerike K; Bélanger PM; Turgeon J
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1196-201. PubMed ID: 8371133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue distribution of mexiletine enantiomers in rats.
    Igwemezie L; Beatch GN; Walker MJ; McErlane KM
    Xenobiotica; 1991 Sep; 21(9):1153-8. PubMed ID: 1788983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic analysis using a highly sensitive fluorogenic reagent, 2-anthroyl chloride, and stereoselective determination of the enantiomers of mexiletine in human serum.
    Kowk DK; Igwemezie L; Kerr CR; McErlane KM
    J Chromatogr B Biomed Appl; 1994 Nov; 661(2):271-80. PubMed ID: 7894667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings.
    Labbé L; O'Hara G; Lefebvre M; Lessard E; Gilbert M; Adedoyin A; Champagne J; Hamelin B; Turgeon J
    Clin Pharmacol Ther; 2000 Jul; 68(1):44-57. PubMed ID: 10945315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependency of salivary excretion of mexiletine on the plasma concentration in rats.
    Nagasako S; Iwamoto K; Hayashibara M; Katagiri Y
    J Pharm Pharmacol; 1993 Feb; 45(2):154-6. PubMed ID: 8095536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary excretion of mexiletine in normal healthy volunteers.
    Katagiri Y; Nagasako S; Hayashibara M; Iwamoto K
    J Pharm Pharmacol; 1991 Jul; 43(7):513-5. PubMed ID: 1682467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ciprofloxacin on the stereoselective disposition of mexiletine in man.
    Labbé L; Robitaille NM; Lefez C; Potvin D; Gilbert M; O'Hara G; Turgeon J
    Ther Drug Monit; 2004 Oct; 26(5):492-8. PubMed ID: 15385831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic determination of mexiletine enantiomers in plasma using direct and indirect enantioselective separations.
    Lanchote VL; Bonato PS; Dreossi SA; Gonçalves PV; Cesarino EJ; Bertucci C
    J Chromatogr B Biomed Appl; 1996 Oct; 685(2):281-9. PubMed ID: 8953169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum binding of tocainide and its enantiomers in human subjects.
    Sedman AJ; Bloedow DC; Gal J
    Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):165-8. PubMed ID: 6815740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary excretion of mexiletine after bolus intravenous administration in rats.
    Nagasako S; Hayashibara M; Katagiri Y; Iwamoto K
    J Pharm Pharmacol; 1992 Jan; 44(1):55-7. PubMed ID: 1350630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective disposition of flurbiprofen in uraemic patients.
    Knadler MP; Brater DC; Hall SD
    Br J Clin Pharmacol; 1992 Apr; 33(4):377-83. PubMed ID: 1576066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
    Główka FK; Caldwell J
    Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human pharmacokinetics and metabolism of disopyramide enantiomers.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.